Luis Diaz, co-founder of PGDx, said the new funding will allow the company to “go out and sell” the cancer diagnostics tech it has been working on for a decade.
Image: Baltimore’s Personal Genome Diagnostics (PGDx) has raised about $214 million in funding to date. CARLEY MILLIGAN
{iframe}https://www.bizjournals.com/baltimore/news/2021/02/10/pgdx-raises-mega-deal-103-m-series-c.html{/iframe}